DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA1073 |
Fewer cells and higher apoptosis |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA2014 |
Microsatellite instability in hematopoietic stem cells and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
MLH1 |
— |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2013 |
Number and differentiation potential of adipose tissue-derived stem cells declines with age |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA934 |
Number of mature B cells leaving the bone marrow declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA1991 |
Hematopoietic cells accumulate random mutations |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2458 |
hypothetical protein LOC146433 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
IL34 |
27.7% Decrease DNA Methylation |
|
DAA2439 |
hypothetical protein LOC283598 increases with age |
Molecular |
mesenchymal stem cell |
Human |
C14orf177 |
42.5% Increase DNA Methylation |
|
DAA2463 |
Level of miR-19a decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR19A |
40.7% Decrease miRNA Level |
|
DAA2462 |
Level of miR-519d decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR519D |
44.7% Decrease miRNA Level |
|
DAA2445 |
L-pipecolic acid oxidase increases with age |
Molecular |
mesenchymal stem cell |
Human |
PIPOX |
32.2% Increase DNA Methylation |
|
DAA2449 |
microfibrillar associated protein 5 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MFAP5 |
46.4% Decrease DNA Methylation |
|
DAA2434 |
nerve growth factor; beta polypeptide precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
NGF |
22.5% Decrease DNA Methylation |
|
DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|
DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZMYND8 |
19.9% Increase DNA Methylation |
|
DAA2447 |
protein kinase N1 isoform 2 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PKN1 |
27.7% Increase DNA Methylation |
|
DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|